Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.523ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.523ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.36.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.36.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.36.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.418EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.418ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.418ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.418EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.418EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.418ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.389EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.389EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.389ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.389ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.389EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.389EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.389ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.389ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.53EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.1.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.1.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.11.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used